• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双侧非典型股骨骨折患者在使用双膦酸盐治疗或联合特立帕肽治疗后的不同手术结局。

Different surgical outcomes in a patient with bilateral atypical femoral fracture related to bisphosphonate use with or without teriparatide treatment.

机构信息

Department of Orthopedics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, 100730, China.

Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, 100730, China.

出版信息

Osteoporos Int. 2019 Nov;30(11):2349-2354. doi: 10.1007/s00198-019-05131-2. Epub 2019 Aug 19.

DOI:10.1007/s00198-019-05131-2
PMID:31428823
Abstract

Bisphosphonates (BPs) are first-line drugs for the treatment of osteoporotic fractures, but long-term use of BP reduces bone turnover and is associated with atypical femur fractures (AFFs). Additionally, BP treatment may cause delayed fracture healing or nonunion, which makes AFF treatment difficult. The incidence of AFF is generally low. In fact, there are only a few clinical reports of AFF and there is no controlled study on AFF treatment. Herein, we report a case of multiple osteoporotic fractures. After 5 years of BP treatment, left and right AFFs occurred within 2 years. The fracture types and surgical operations were the same, but the level of bone metabolism and drug treatment were different. The right AFF healed well following teriparatide initiation compared with non-healed left AFF with BP continuation; thus, our case can be considered a self-controlled study. Furthermore, we have reviewed the diagnosis and treatment of this case in detail and analyzed and investigated the potential causes of the different outcomes of AFFs between the two sides to inform the clinical treatment of atypical fractures. Mini Abstract We report a case of bilateral AFFs. The surgical treatments were the same, but the final treatment outcomes were different with or without teriparatide treatment. We investigated the potential causes of the different outcomes of AFFs between the two sides to inform the clinical treatment of AFFs.

摘要

双膦酸盐(BPs)是治疗骨质疏松性骨折的一线药物,但长期使用 BP 会降低骨转换率,并与非典型股骨骨折(AFFs)相关。此外,BP 治疗可能导致骨折愈合延迟或不愈合,这使得 AFF 的治疗变得困难。AFF 的发病率一般较低。事实上,仅有少数关于 AFF 的临床报告,且没有关于 AFF 治疗的对照研究。在此,我们报告一例多发性骨质疏松性骨折病例。在 BP 治疗 5 年后,2 年内左右两侧均发生 AFF。骨折类型和手术操作相同,但骨代谢和药物治疗水平不同。与继续 BP 治疗而未愈合的左侧 AFF 相比,开始使用特立帕肽后右侧 AFF 愈合良好;因此,我们的病例可以被认为是一个自身对照研究。此外,我们详细回顾了该病例的诊断和治疗,并分析和探讨了两侧 AFF 不同结局的潜在原因,为 AFF 的临床治疗提供参考。

相似文献

1
Different surgical outcomes in a patient with bilateral atypical femoral fracture related to bisphosphonate use with or without teriparatide treatment.双侧非典型股骨骨折患者在使用双膦酸盐治疗或联合特立帕肽治疗后的不同手术结局。
Osteoporos Int. 2019 Nov;30(11):2349-2354. doi: 10.1007/s00198-019-05131-2. Epub 2019 Aug 19.
2
The effects of teriparatide on acceleration of bone healing following atypical femoral fracture: comparison between daily and weekly administration.特立帕肽对非典型股骨骨折后骨愈合加速的影响:每日和每周给药的比较。
Osteoporos Int. 2018 Dec;29(12):2659-2665. doi: 10.1007/s00198-018-4658-7. Epub 2018 Aug 13.
3
Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide.骨质疏松症患者中双膦酸盐相关非典型股骨骨折的愈合:特立帕肽治疗与未治疗的比较。
J Bone Miner Metab. 2015 Sep;33(5):553-9. doi: 10.1007/s00774-014-0617-3. Epub 2014 Sep 17.
4
Medical Management of Patients After Atypical Femur Fractures: a Systematic Review and Recommendations From the European Calcified Tissue Society.非典型股骨骨折患者的医学管理:来自欧洲钙化组织协会的系统评价和建议。
J Clin Endocrinol Metab. 2020 May 1;105(5):1682-99. doi: 10.1210/clinem/dgz295.
5
Medication management after intramedullary nailing of atypical fractures.非典型骨折髓内钉固定术后的药物管理
Injury. 2017 Jun;48 Suppl 1:S15-S17. doi: 10.1016/j.injury.2017.04.030. Epub 2017 Apr 26.
6
Responses to Treatment With Teriparatide in Patients With Atypical Femur Fractures Previously Treated With Bisphosphonates.曾接受双膦酸盐治疗的非典型股骨骨折患者使用特立帕肽治疗的反应。
J Bone Miner Res. 2017 May;32(5):1027-1033. doi: 10.1002/jbmr.3081. Epub 2017 Feb 7.
7
Current Understanding of Epidemiology, Pathophysiology, and Management of Atypical Femur Fractures.对非典型股骨骨折的流行病学、病理生理学和治疗的现有认识。
Curr Osteoporos Rep. 2018 Aug;16(4):519-529. doi: 10.1007/s11914-018-0464-6.
8
Incidence, risk factors, and fracture healing of atypical femoral fractures: a multicenter case-control study.非典型股骨骨折的发生率、风险因素和骨折愈合:一项多中心病例对照研究。
Osteoporos Int. 2018 Nov;29(11):2427-2435. doi: 10.1007/s00198-018-4640-4. Epub 2018 Jul 23.
9
Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur.特立帕肽治疗双膦酸盐相关性股骨非典型骨折患者。
Osteoporos Int. 2018 Feb;29(2):501-506. doi: 10.1007/s00198-017-4286-7. Epub 2017 Oct 30.
10
Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment.在接受或未接受特立帕肽治疗的骨质疏松症患者中,与使用双膦酸盐相关的非典型转子下和股骨骨折的手术结果。
BMC Musculoskelet Disord. 2017 Dec 13;18(1):527. doi: 10.1186/s12891-017-1878-5.

引用本文的文献

1
Global current research status and future hotspots in osteoporotic fracture based on bibliometric assessment and visualization techniques.基于文献计量学评估和可视化技术的骨质疏松性骨折全球当前研究现状与未来热点
World J Clin Cases. 2024 Jul 6;12(19):3908-3917. doi: 10.12998/wjcc.v12.i19.3908.
2
Bilateral Atypical Femoral Fractures after Bisphosphonate Treatment for Osteoporosis: A Literature Review.双膦酸盐治疗骨质疏松症后双侧非典型股骨骨折:文献综述
J Clin Med. 2023 Jan 29;12(3):1038. doi: 10.3390/jcm12031038.
3
Successful Revision with INTERTAN for a Blade Cut Through in PFNA Fixation: A Case Report.

本文引用的文献

1
The association of race/ethnicity and risk of atypical femur fracture among older women receiving oral bisphosphonate therapy.接受口服双膦酸盐治疗的老年女性中种族/民族与非典型股骨骨折风险的关联。
Bone. 2016 Apr;85:142-7. doi: 10.1016/j.bone.2016.01.002. Epub 2016 Jan 6.
2
Anti-Osteoporotic Therapy After Fragility Fracture Lowers Rate of Subsequent Fracture: Analysis of a Large Population Sample.脆性骨折后抗骨质疏松治疗可降低后续骨折发生率:一项大样本人群分析。
J Bone Joint Surg Am. 2015 Oct 7;97(19):1555-62. doi: 10.2106/JBJS.N.01275.
3
Risk of atypical femoral fracture during and after bisphosphonate use.
INTERTAN 治疗 PFNA 固定后刀片切割的翻修手术:病例报告。
Orthop Surg. 2023 Mar;15(3):906-911. doi: 10.1111/os.13656. Epub 2023 Jan 29.
4
A brief review and clinical evidences of teriparatide therapy for atypical femoral fractures associated with long-term bisphosphonate treatment.特立帕肽治疗与长期双膦酸盐治疗相关的非典型股骨骨折的简要综述及临床证据
Front Surg. 2023 Jan 6;9:1063170. doi: 10.3389/fsurg.2022.1063170. eCollection 2022.
5
Radiological Reversibility of Incomplete Atypical Femoral Fracture with Cessation of Bisphosphonate: Including an Early Stage of Incomplete Fracture.停用双膦酸盐后不完全性非典型股骨骨折的放射学可逆性:包括不完全骨折的早期阶段。
Indian J Orthop. 2022 Apr 22;56(6):1023-1032. doi: 10.1007/s43465-022-00639-y. eCollection 2022 Jun.
6
Fracture Risk Following an Atypical Femoral Fracture.非典型股骨骨折后的骨折风险。
J Bone Miner Res. 2022 Jan;37(1):87-94. doi: 10.1002/jbmr.4461. Epub 2021 Nov 9.
7
Management Challenges in Atypical Femoral Fractures: A Case Report.非典型股骨骨折的管理挑战:病例报告
Ann Geriatr Med Res. 2020 Mar;24(1):50-54. doi: 10.4235/agmr.19.0046. Epub 2020 Mar 24.
使用双膦酸盐期间及之后非典型股骨骨折的风险。
N Engl J Med. 2014 Sep 4;371(10):974-6. doi: 10.1056/NEJMc1403799.
4
Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research.非典型股骨转子下和骨干骨折:美国骨与矿物质研究学会特别工作组的第二次报告
J Bone Miner Res. 2014 Jan;29(1):1-23. doi: 10.1002/jbmr.1998. Epub 2013 Oct 1.
5
Incidence of atypical nontraumatic diaphyseal fractures of the femur.股骨非典型非外伤性骨干骨折的发生率。
J Bone Miner Res. 2012 Dec;27(12):2544-50. doi: 10.1002/jbmr.1719.
6
Atypical femoral fracture risk in patients treated with bisphosphonates.接受双膦酸盐治疗患者的非典型股骨骨折风险。
Arch Intern Med. 2012 Jun 25;172(12):936-7. doi: 10.1001/archinternmed.2012.1827.
7
Increasing occurrence of atypical femoral fractures associated with bisphosphonate use.与双膦酸盐使用相关的非典型股骨骨折发生率不断增加。
Arch Intern Med. 2012 Jun 25;172(12):930-6. doi: 10.1001/archinternmed.2012.1796.
8
Bisphosphonate use and atypical fractures of the femoral shaft.双膦酸盐类药物的应用与股骨干非典型骨折。
N Engl J Med. 2011 May 5;364(18):1728-37. doi: 10.1056/NEJMoa1010650.
9
Nonoperative versus prophylactic treatment of bisphosphonate-associated femoral stress fractures.非手术与预防性治疗双膦酸盐相关性股骨干应力性骨折。
Clin Orthop Relat Res. 2011 Jul;469(7):2028-34. doi: 10.1007/s11999-011-1828-8. Epub 2011 Feb 25.
10
Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women.双膦酸盐的使用与老年女性转子下或股骨干骨折的风险。
JAMA. 2011 Feb 23;305(8):783-9. doi: 10.1001/jama.2011.190.